The ACB published an immediate public press release to the Carter Report
publication on Wednesday, but has now prepared a detailed commentary on the
various issues raised in the report for the benefit of ACB members and
especially those members involved in the pilot projects.
ACB Members have been individually emailed this extended commentary this
morning but if your email servers prevented delivery of the attachment, or
you have not provided us with a current email contact address, then you can
download the document from the ACB Members area of the our website.
My apologies to members in the neighbouring countries of our islands and
others in the wider global community.
While the Carter Review is concerned purely with pathology in England, ACB
members in all countries will have had the notifications as they may be
interested in developments in England for comparative purposes with the
situation in their own countries (feeling pleased - or saddened - that they
don't have it in place in their country, or preparing for what might yet
materialise there in the future). Alternatively they may in time need to
be working in English laboratories and so be more appreciative of the
situation pertaining here.
For members employed in the Health Service in England, the Carter Review is
the most important document to have been published on the organisation and
delivery of pathology and laboratory medicine and has major implications
for the profession.
Graham Groom
Senior Administrator - ACB
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
|